about
NK Cell Inflammation in the Clinical Outcome of Colorectal CarcinomaLicensing delineates helper and effector NK cell subsets during viral infection.NK cells and T cells cooperate during the clinical course of colorectal cancer.Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differentiaRole of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients.Prolonged contact with dendritic cells turns lymph node-resident NK cells into anti-tumor effectors.NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention.Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy
P2860
Q26991949-792DEC16-85CB-4E77-9C51-5A7656B6BDD7Q33703214-A515FDC3-538D-484D-B098-81FD0C14EC6DQ34933101-996E9FF0-3C6F-4811-9BA3-B6117617CD22Q35743162-CB5C4316-F51B-477E-AEFD-7BFBDDEAFF4EQ37171499-4C1B6C97-7370-4F34-9BB9-D68A7A59946DQ37222064-44793E6F-935F-47E9-A36F-90270DBD81ECQ37228973-BCF6F7F9-EE57-43B8-9A79-13CAE1C6922EQ37616478-85C29DD6-1213-40DC-BA92-82B22F8AB860Q38860610-736F88C0-1EFA-4DB7-BF38-681B3E7D2AA7Q54369697-06574A33-6FD4-49A8-82A3-B8CA0E3AC4E2Q58787920-D8C931F8-3D69-4B52-A4C4-AAF9E1DF3CBA
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Natural killer cells in non-hematopoietic malignancies
@ast
Natural killer cells in non-hematopoietic malignancies
@en
type
label
Natural killer cells in non-hematopoietic malignancies
@ast
Natural killer cells in non-hematopoietic malignancies
@en
prefLabel
Natural killer cells in non-hematopoietic malignancies
@ast
Natural killer cells in non-hematopoietic malignancies
@en
P2860
P50
P356
P1476
Natural killer cells in non-hematopoietic malignancies
@en
P2093
Mélanie Desbois
P2860
P356
10.3389/FIMMU.2012.00395
P577
2012-12-24T00:00:00Z